rs34406289
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP3BP4_ModerateBP6BS1BS2
The NM_016169.4(SUFU):c.412G>A(p.Ala138Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016169.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUFU | ENST00000369902.8 | c.412G>A | p.Ala138Thr | missense_variant | Exon 3 of 12 | 1 | NM_016169.4 | ENSP00000358918.4 | ||
SUFU | ENST00000423559.2 | c.412G>A | p.Ala138Thr | missense_variant | Exon 3 of 10 | 1 | ENSP00000411597.2 | |||
SUFU | ENST00000369899.6 | c.412G>A | p.Ala138Thr | missense_variant | Exon 3 of 11 | 1 | ENSP00000358915.2 |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251480Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135912
GnomAD4 exome AF: 0.0000917 AC: 134AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000729 AC XY: 53AN XY: 727246
GnomAD4 genome AF: 0.000722 AC: 110AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
- -
- -
not provided Uncertain:1Benign:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with chordoma (Yepes 2021); This variant is associated with the following publications: (PMID: 24311597, 34070849, 25589003) -
- -
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
SUFU-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Gorlin syndrome;C0025149:Medulloblastoma Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at